Related Experiment Video
Updated: Jul 12, 2026
10:26
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
p16INK4a expression in invasive vulvar squamous cell carcinoma
Barbara Tringler1, Christoph Grimm, Grazyna Dudek
1Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria. b.tringler@salk.at
Applied Immunohistochemistry & Molecular Morphology : AIMM
|August 28, 2007
Summary
p16 protein expression may indicate a better prognosis for patients with invasive vulvar squamous cell carcinoma. Further research is needed to confirm its prognostic value in vulvar cancer.
Area of Science:
- Oncology
- Cell Biology
Background:
- p16 (INK4a) is a cell cycle regulator.
- p16 is a biomarker for cervical intraepithelial neoplasia.
- Limited data exist on p16 in vulvar cancer.
Purpose of the Study:
- Evaluate p16 expression in vulvar squamous cell carcinoma.
- Correlate p16 with clinicopathologic factors and survival.
- Determine the prognostic significance of p16 in vulvar cancer.
Main Methods:
- Immunohistochemistry used to assess p16 expression.
- 80 cases of invasive vulvar squamous cell carcinoma analyzed.
- Correlation with clinicopathologic parameters and survival data.
Main Results:
- p16 expression found in 43% of cases (34/80).
- Expression localized to tumor cell cytoplasm and nuclei.
- Univariate analysis showed p16 positivity associated with longer survival.
- Multivariate analysis did not confirm p16 as an independent prognostic factor.
Conclusions:
- p16 expression is present in a significant subset of vulvar squamous cell carcinoma.
- p16 may hold prognostic significance in vulvar cancer.
- Further studies are warranted to validate p16 as a prognostic marker.
